Polydeoxyribonucleotide (PDRN) has emerged as the gold standard in regenerative medicine and advanced cosmeceuticals. As a DNA fragment derived from salmon sperm, PDRN acts as a powerful tissue repair-stimulating agent. For global brands and pharmaceutical companies, finding a reliable OEM Skin Repair PDRN Manufacturer is no longer just about sourcing—it's about partnering with a technologist who understands molecular weight precision and biological activity.
At Shaanxi Bieyouth Biotech Co., Ltd., we bridge the gap between clinical research and mass-market scalability. Established in 2018, our journey has been defined by a commitment to high-purity extraction. We provide "Information Gain" to our partners by sharing deep insights into how PDRN interacts with adenosine A2A receptors to promote angiogenesis and collagen synthesis, ensuring your finished product delivers measurable results.
Our proprietary enzymatic cleavage technology allows us to produce PDRN with precise molecular weights (50-1500 kDa), tailored for specific absorption depths in dermal layers.
Utilizing multi-stage chromatography, we achieve a DNA purity of >98%, with minimal protein and lipid contaminants, reducing the risk of immune response.
Future Outlook: We are investing in non-animal origin DNA precursors through microbial fermentation to ensure a sustainable and vegan-friendly supply chain by 2027.
Shaanxi Bieyouth Biotech Co., Ltd. is a large-scale gold supplier integrating production and sales. We specialize in plant and animal extracts, cosmetic raw materials, and pharmaceutical ingredients. Our production facilities are GMP certified, featuring two standardized production workshops and state-of-the-art extraction equipment.
Tons Annual Capacity
Levels of QC
Year Established
We don't just supply raw materials; we provide comprehensive solutions for the skin repair ecosystem.
Sterile-grade PDRN for injectable mesotherapy, promoting rapid healing after laser treatments and chemical peels.
High-permeability PDRN formulations for serums, creams, and sheet masks targeting anti-aging and barrier repair.
Biomedical applications for diabetic foot ulcers and chronic wound management through accelerated tissue granulation.
| Feature | Traditional Manufacturing | Bieyouth Factory 4.0 Advantage |
|---|---|---|
| Automation | Manual batch processing | Fully automated PLC extraction lines |
| Quality Control | Spot checks | Real-time inline molecular sensor monitoring |
| Traceability | Paper-based logs | Blockchain-enabled batch tracking from raw DNA source |
| Response Time | 4-6 weeks | Rapid OEM prototyping in under 10 days |
Our China Factory 4.0 model ensures efficiency and price competitiveness. By locating our production hub in Shaanxi, we leverage local logistical advantages while maintaining international FDA and GMP compliance standards.
In-depth discussion on target molecular weight, concentration, and application form (liquid, powder, or gel).
Our "Institute of Biology" crafts a custom prototype. We provide COA, HPLC reports, and stability data.
Mass production in our 50,000-ton capacity facility with rigorous 5-level quality control.
Navigating global regulatory landscapes is complex. As a veteran exporter to the USA, UK, Canada, Russia, and Australia, we provide full documentary support:
Bieyouth
